Your account is not claimed yet. You can sign up with ORCID to claim your account.

Vaibhavkumar S Gawali

Years Active: 2017-2022
Publications (10 Years): 4

Medical University of Vienna (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Medical University of Vienna Dec 13o 2011 - Apr 29o 2016

Austria

PHD :: Neurophysiology and Neuropharmacology

Publications

Martina Chirra, Hannah S Newton, Vaibhavkumar S Gawali, Trisha M Wise-Draper, Ameet A Chimote, Laura Conforti
How the Potassium Channel Response of T Lymphocytes to the Tumor Microenvironment Shapes Antitumor Immunity. Cancers 14 (15) (2022)
Hannah S Newton, Vaibhavkumar S Gawali, Ameet A Chimote, Maria A Lehn, Sarah M Palackdharry, Benjamin H Hinrichs, Roman Jandarov, David Hildeman, Edith M Janssen, Trisha M Wise-Draper, Laura Conforti
PD1 blockade enhances K+ channel activity, Ca2+ signaling, and migratory ability in cytotoxic T lymphocytes of patients with head and neck cancer. Journal for immunotherapy of cancer 8 (2) (2021)
Abigail Koehler, Aniruddha S Karve, Pankaj Desai, Jack Arbiser, David R Plas, Xiaoyang Qi, Renee D Read, Atsuo T Sasaki, Vaibhavkumar S Gawali, Donatien K Toukam, Debanjan Bhattacharya, Laura Kallay, Daniel A Pomeranz Krummel, Soma Sengupta
Reuse of Molecules for Glioblastoma Therapy. Pharmaceuticals (Basel, Switzerland) 14 (2) (2021)
Vaibhavkumar S Gawali, Svilen Simeonov, Martina Drescher, Thomas Knott, Olaf Scheel, John Kudolo, Hanspeter Kählig, Ulla Hochenegg, Alexander Roller, Hannes Todt, Nuno Maulide
C2-Modified Sparteine Derivatives Are a New Class of Potentially Long-Acting Sodium Channel Blockers. ChemMedChem 12 (22) (2017)

Vaibhavkumar S Gawali.css-eqlu8i{font-size:small;padding-left:4px;}